July 24, 2019 — The majority of clinics offering stem-cell therapies in the United States do not employ physicians with training in the fields they claim to treat. This is according to a paper published on June 25 in the Journal of the American Medical Association (JAMA).
Fewer than half of the 166 businesses researched employed clinicians whose formal medical training aligned with the conditions being managed.
Okyanos has assembled a multi-disciplinary team of specialists that includes board-certified surgeons, registered nurses and medical technicians who are trained in their specialties as well as the delivery of stem cell therapies. Its world-class doctors are experts in their fields.
In the U.S., stem cells can be taken and reinjected without FDA approval as long as the cells have been “minimally manipulated.” The FDA has been cracking down in recent months on clinics whose practices do not meet its standards.
Okyanos Center For Regenerative Medicine is closely regulated by the Bahamian regulatory authorities. Okyanos’s treatment protocols have been reviewed by Bahamian agencies, including the National Stem Cell Ethics Committee, and have been shown to be both safe and, for many, effective.
Although any medical procedure has risks, adult stem cell therapy can be safely performed when done by competent clinicians well trained in the science of stem cells.